Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens μ-opiate-mediated feeding behavior

ML Perry, BA Baldo, ME Andrzejewski… - Behavioural brain …, 2009 - Elsevier
Intra-nucleus accumbens (Acb) infusion of cholinergic muscarinic antagonist, scopolamine
(10μg/0.5 μl), markedly reduced fat intake elicited by intra-Acb treatment of the μ-opioid …
被引用次数：38 相关文章

[引用][C] Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens μ-opiate-mediated feeding behavior

ML PERRY, BA BALDO… - Behavioural brain …, 2009 - pascal-francis.inist.fr
Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens μ-opiate-mediated
feeding behavior CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens μ-opiate-mediated feeding behavior

ML Perry, BA Baldo, ME Andrzejewski… - Behavioural Brain …, 2009 - infona.pl
Intra-nucleus accumbens (Acb) infusion of cholinergic muscarinic antagonist, scopolamine
(10μg/0.5 μl), markedly reduced fat intake elicited by intra-Acb treatment of the μ-opioid …

Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens mu-opiate-mediated feeding behavior.

ML Perry, BA Baldo, ME Andrzejewski… - Behavioural Brain …, 2008 - europepmc.org
Obesity is currently a major health problem in the world today. While a great deal of research
has focused on mechanisms controlling food intake and appetite, there has been little …

Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens μ-opiate-mediated feeding behavior.

ML Perry, BA Baldo, ME Andrzejewski… - Behavioural Brain …, 2009 - psycnet.apa.org
Intra-nucleus accumbens (Acb) infusion of cholinergic muscarinic antagonist, scopolamine
(10 μg/0.5 μl), markedly reduced fat intake elicited by intra-Acb treatment of the μ-opioid …

Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens mu-opiate-mediated feeding behavior

ML Perry, BA Baldo… - Behavioural brain …, 2009 - pubmed.ncbi.nlm.nih.gov
Intra-nucleus accumbens (Acb) infusion of cholinergic muscarinic antagonist, scopolamine
(10 microg/0.5 microl), markedly reduced fat intake elicited by intra-Acb treatment of the mu …
[PDF] academia.edu

[PDF][PDF] Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens μ-opiate-mediated feeding behavior

ML Perry, BA Baldo, AE Kelley - Behav Brain Res, 2009 - academia.edu
Obesity is currently a major health problem in the world today. While a great deal of research
has focused on mechanisms controlling food intake and appetite, there has been little …
[HTML] nih.gov

[HTML][HTML] Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens μ-opiate-mediated feeding behavior

ML Perry, BA Baldo, ME Andrzejewski… - Behavioural brain …, 2009 - ncbi.nlm.nih.gov
Obesity is currently a major health problem in the world today. While a great deal of research
has focused on mechanisms controlling food intake and appetite, there has been little …

Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens mu-opiate-mediated feeding behavior.

ML Perry, BA Baldo, ME Andrzejewski… - Behavioural Brain …, 2008 - europepmc.org
Intra-nucleus accumbens (Acb) infusion of cholinergic muscarinic antagonist, scopolamine
(10 microg/0.5 microl), markedly reduced fat intake elicited by intra-Acb treatment of the mu …
[PDF] academia.edu

[PDF][PDF] Muscarinic receptor antagonism causes a functional alteration in nucleus accumbens-opiate-mediated feeding behavior

ML Perry, BA Baldo, ME Andrzejewski… - Behavioural Brain …, 2009 - academia.edu
abstract Intra-nucleus accumbens (Acb) infusion of cholinergic muscarinic antagonist,
scopolamine (10 g/0.5 l), markedly reduced fat intake elicited by intra-Acb treatment of the …